Phase II Study of Docetaxel, Estramustine, and Low-Dose Hydrocortisone in Men With Hormone-Refractory Prostate Cancer: A Final Report of CALGB 9780 PURPOSE: Studies reporting effects of radiotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results